This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2010-2011.
Location History:
- Molndal, SE (2010)
- Mölndal, SE (2011)
Company Filing History:
Years Active: 2010-2011
Title: Christina Olsson: Innovator in Cardiac Treatment
Introduction
Christina Olsson is a prominent inventor based in Molndal, Sweden. She has made significant contributions to the field of cardiac treatment through her innovative research and development of new compounds. With a total of 2 patents, her work focuses on addressing critical health issues related to cardiac arrhythmias.
Latest Patents
Christina's latest patents include groundbreaking compounds designed for the treatment of cardiac arrhythmias. The first patent, titled "Oxabispidine compounds for the treatment of cardiac arrhythmias," provides compounds of formula I, wherein R, R, R, R to R, X, Y, and Z have meanings given in the description. These compounds are particularly useful in the prophylaxis and treatment of both atrial and ventricular arrhythmias. The second patent, "Oxabispidine compounds and their use in the treatment of cardiac arrhythmias," also details compounds of formula (I) with similar applications, emphasizing their importance in managing arrhythmias.
Career Highlights
Christina Olsson is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to collaborate with other experts in the field and contribute to the development of innovative treatments for cardiovascular diseases.
Collaborations
Some of Christina's notable coworkers include Annika Björe and Johan Kajanus. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion
Christina Olsson's contributions to cardiac treatment through her patents and work at AstraZeneca AB highlight her dedication to improving patient outcomes. Her innovative approach to addressing cardiac arrhythmias positions her as a key figure in the field of medical research.